• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中细胞周期蛋白依赖性激酶抑制剂p27kip1的Akt依赖性T198磷酸化

Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.

作者信息

Motti Maria Letizia, De Marco Carmela, Califano Daniela, Fusco Alfredo, Viglietto Giuseppe

机构信息

Dipartimento di Biologia e Patologia Cellulare e Molecolare L Califano Facoltà di Medicina e Chirurgia, Università Federico II, via S. Pansini 5, Napoli, Italy.

出版信息

Cell Cycle. 2004 Aug;3(8):1074-80. Epub 2004 Aug 7.

PMID:15280662
Abstract

The localization of the cyclin-dependent kinase inhibitor p27(kip1) is dependent on the phosphorylation of one of three key amino acid residues: S10, T157 and T198. However, it was unclear whether endogenous p27(kip1) is phosphorylated at T198 in the living cell. In the present work we describe the generation and characterization of a polyclonal antibody able to recognize recombinant, transfected as well as endogenous T198-phosphorylated p27(kip1). Using this antibody, we demonstrate that: (1) endogenous p27(kip1) is phosphorylated at T198 in 4 breast cancer cells lines (MCF7, MDA-MB231, MDA- MB436 and MDA-MB468); (2) T198 phosphorylation is increased in breast cancer cells compared with normal mammary epithelial cells (HMEC); (3) T198-phosphorylated p27(kip1) is exclusively cytoplasmic; (4) T198 phosphorylation is dependent on the activity of the PI3K-PKB/Akt pathway, being it drastically reduced by the pharmacological PI3K inhibitor LY294002 or stimulated by the constitutive activation of PKB/Akt. Finally, in primary human breast carcinomas, cytoplasmic accumulation of T198-phosphorylated p27(kip1) parallels Akt activation. We conclude that in breast cancer cells p27(kip1) is phosphorylated at T198 in a PI3K/Akt dependent manner and that this phosphorylation may contribute to p27(kip1) cytoplasmic mislocalization observed in breast cancer.

摘要

细胞周期蛋白依赖性激酶抑制剂p27(kip1)的定位取决于三个关键氨基酸残基之一的磷酸化:S10、T157和T198。然而,尚不清楚内源性p27(kip1)在活细胞中是否在T198处发生磷酸化。在本研究中,我们描述了一种能够识别重组、转染以及内源性T198磷酸化p27(kip1)的多克隆抗体的产生和特性。使用该抗体,我们证明:(1)在4种乳腺癌细胞系(MCF7、MDA-MB231、MDA-MB436和MDA-MB468)中,内源性p27(kip1)在T198处发生磷酸化;(2)与正常乳腺上皮细胞(HMEC)相比,乳腺癌细胞中T198磷酸化增加;(3)T198磷酸化的p27(kip1)仅存在于细胞质中;(4)T198磷酸化依赖于PI3K-PKB/Akt途径的活性,药理学PI3K抑制剂LY294002可使其显著降低,而PKB/Akt的组成性激活则可刺激其增加。最后在原发性人乳腺癌中,T198磷酸化的p27(kip1)的细胞质积累与Akt激活平行。我们得出结论,在乳腺癌细胞中,p27(kip1)以PI3K/Akt依赖性方式在T198处发生磷酸化,这种磷酸化可能导致乳腺癌中观察到的p27(kip1)细胞质定位错误。

相似文献

1
Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer.乳腺癌中细胞周期蛋白依赖性激酶抑制剂p27kip1的Akt依赖性T198磷酸化
Cell Cycle. 2004 Aug;3(8):1074-80. Epub 2004 Aug 7.
2
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.PI3K/AKT通路对甲状腺癌细胞中细胞周期蛋白依赖性激酶抑制剂p27kip1的复杂调控:p27kip1表达与定位的调控
Am J Pathol. 2005 Mar;166(3):737-49. doi: 10.1016/S0002-9440(10)62295-X.
3
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.在乳腺癌中,蛋白激酶B/蛋白激酶B(PKB/Akt)介导的磷酸化作用导致细胞周期蛋白依赖性激酶抑制剂p27(Kip1)的细胞质重新定位及抑制。
Nat Med. 2002 Oct;8(10):1136-44. doi: 10.1038/nm762. Epub 2002 Sep 16.
4
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.蛋白激酶B/蛋白激酶Akt通过使p27(Kip1)的苏氨酸157位点磷酸化并调节其细胞定位来介导细胞周期进程。
Nat Med. 2002 Oct;8(10):1145-52. doi: 10.1038/nm759. Epub 2002 Sep 16.
5
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.p27Kip1的Akt依赖性磷酸化促进其与14-3-3的结合及胞质定位。
J Biol Chem. 2002 Aug 9;277(32):28706-13. doi: 10.1074/jbc.M203668200. Epub 2002 May 31.
6
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.表皮生长因子受体2/神经生长因子受体激酶通过多种信号通路调节细胞周期蛋白依赖性激酶抑制因子2和细胞周期蛋白D1。
Cancer Res. 2001 Sep 1;61(17):6583-91.
7
p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis.蛋白激酶B/蛋白激酶B(PKB/Akt)介导的p27KIP1磷酸化会导致乳腺癌预后不良。
Breast Cancer Res. 2003;5(3):162-3. doi: 10.1186/bcr596. Epub 2003 Mar 31.
8
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.蛋白激酶B/蛋白激酶Akt使p27磷酸化,损害p27的核输入,并对抗p27介导的G1期阻滞。
Nat Med. 2002 Oct;8(10):1153-60. doi: 10.1038/nm761. Epub 2002 Sep 16.
9
BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.BCR/ABL通过磷脂酰肌醇3激酶/AKT途径调节细胞周期蛋白依赖性激酶抑制剂p27Kip1的表达。
J Biol Chem. 2000 Dec 15;275(50):39223-30. doi: 10.1074/jbc.M007291200.
10
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.赫赛汀诱导的磷脂酰肌醇-3激酶和Akt抑制作用是抗体介导的对p27、细胞周期蛋白D1及抗肿瘤作用的必要条件。
Cancer Res. 2002 Jul 15;62(14):4132-41.

引用本文的文献

1
C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer.C 端磷酸化的 p27 激活自我更新驱动基因,从而调控肿瘤干细胞的扩增、乳腺增生和癌症。
Nat Commun. 2024 Jun 17;15(1):5152. doi: 10.1038/s41467-024-48742-y.
2
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma.曲妥珠单抗的作用机制;二十年的研究以解开一个难题
Cancers (Basel). 2021 Jul 15;13(14):3540. doi: 10.3390/cancers13143540.
3
Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis.
AKT1(p.E17K)热点突变对恶性肿瘤发生及预后的影响
Front Cell Dev Biol. 2020 Oct 6;8:573599. doi: 10.3389/fcell.2020.573599. eCollection 2020.
4
Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC.使用新型噻唑烷酮类抗癌剂 DpC 克服雌激素受体阳性乳腺癌的耐药性。
Br J Pharmacol. 2020 May;177(10):2365-2380. doi: 10.1111/bph.14985. Epub 2020 Feb 12.
5
p27 transcriptionally coregulates cJun to drive programs of tumor progression.p27 通过转录调控 cJun 以驱动肿瘤进展的程序。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7005-7014. doi: 10.1073/pnas.1817415116. Epub 2019 Mar 15.
6
Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.胰岛素/IGF-1 通过 PI3K/Akt 增强肥胖人群的肠道上皮隐窝增殖,而非通过 ERK 信号通路。
Exp Biol Med (Maywood). 2018 Jul;243(11):911-916. doi: 10.1177/1535370218785152. Epub 2018 Jun 27.
7
Regulation of p27 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G.蛋白磷酸酶PPM1G对p27磷酸化及G1期细胞周期进程的调控
Am J Cancer Res. 2016 Oct 1;6(10):2207-2220. eCollection 2016.
8
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.p27是骨肉瘤的一种潜在预后生物标志物和转移促进因子。
Cancer Res. 2016 Jul 1;76(13):4002-11. doi: 10.1158/0008-5472.CAN-15-3189. Epub 2016 Apr 19.
9
The B56γ3 regulatory subunit-containing protein phosphatase 2A outcompetes Akt to regulate p27KIP1 subcellular localization by selectively dephosphorylating phospho-Thr157 of p27KIP1.含B56γ3调节亚基的蛋白磷酸酶2A通过选择性地使p27KIP1的磷酸化苏氨酸157去磷酸化,从而胜过Akt来调节p27KIP1的亚细胞定位。
Oncotarget. 2016 Jan 26;7(4):4542-58. doi: 10.18632/oncotarget.6609.
10
SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.小泛素样修饰(SUMO)化作用可调节p27Kip1的稳定性及定位,以响应转化生长因子β(TGFβ)。
J Mol Cell Biol. 2016 Feb;8(1):17-30. doi: 10.1093/jmcb/mjv056. Epub 2015 Oct 8.